Company · founded 2012
Immuno Technologies (United States)
Memphis, United States · immuno-technologies-inc.myshopify.com
- Citations, last 5 years
- 40
- Works, last 5 years
- 7
- h-index
- 17
- Scientists listed
- 0
- Grants since 2016
- 7
Grants received
2022–2026 · research · R44
Intranasal Vaccine Against Lyme Disease
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Intranasal Vaccine Against Lyme Disease
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2022–2025 · research · R44
Intranasal Vaccine Against Lyme Disease
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2020–2023 · research · R43
Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease.
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease.
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Point of care assay for serodiagnosis of Leptospirosis
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health
2017–2020 · research · R43
Point of care assay for serodiagnosis of Leptospirosis
Maria Gomes-Solecki · Immuno Technologies (United States) · funded by National Institutes of Health